Childhood Spinal Cord Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Childhood Spinal Cord Neoplasm

subtype

Identifier: CI-CAN-00002336
Entity page: /cancer/childhood-spinal-cord-neoplasm ↗
Edges: 16

Neighbours: 8 drugs8 trials
Drawn: 16 of 16 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Childhood Spinal Cord Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived8 of 8
→ investigated in trials for	Temozolomidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Childhood Spinal Cord Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants

Childhood Spinal Cord Neoplasm studied in …STUDIED_INderived8 of 8
→ studied in	NCT01236560Phase 2/Phase 3 · completed Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00381797Phase 2 · completed Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00326664Phase 1 · completed AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors · condition mapped ONTOLOGY_EXACT · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped CURATED_BROADER · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00946335Phase 1 · completed ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors · condition mapped CURATED_BROADER · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01076530Phase 1 · completed Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors · condition mapped CURATED_BROADER · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00053963Phase 1 · completed FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT00363272Phase 1 · completed Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (0 active)	—	—	Childhood Spinal Cord Neoplasm	1	Observed	clinicaltrials	graph →